nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—IFNG—psoriasis	0.334	0.705	CbGaD
Glucosamine—osteoarthritis—Prednisone—psoriasis	0.333	1	CpDpCtD
Glucosamine—TNF—psoriasis	0.14	0.295	CbGaD
Glucosamine—MMP9—synovial fluid—psoriasis	0.0108	0.193	CbGeAlD
Glucosamine—IFNG—synovial membrane of synovial joint—psoriasis	0.00829	0.148	CbGeAlD
Glucosamine—MMP9—dermis—psoriasis	0.00811	0.145	CbGeAlD
Glucosamine—CYP2C19—Cholecalciferol—psoriasis	0.00705	0.288	CbGbCtD
Glucosamine—MMP9—skeletal joint—psoriasis	0.007	0.125	CbGeAlD
Glucosamine—IFNG—skin epidermis—psoriasis	0.00532	0.0947	CbGeAlD
Glucosamine—CYP2C19—Prednisone—psoriasis	0.00488	0.2	CbGbCtD
Glucosamine—CYP2E1—Dexamethasone—psoriasis	0.00486	0.199	CbGbCtD
Glucosamine—CYP2C19—Cyclosporine—psoriasis	0.00463	0.189	CbGbCtD
Glucosamine—IFNG—endothelium—psoriasis	0.00386	0.0687	CbGeAlD
Glucosamine—MMP9—skin epidermis—psoriasis	0.00341	0.0608	CbGeAlD
Glucosamine—CYP2C19—Dexamethasone—psoriasis	0.00305	0.125	CbGbCtD
Glucosamine—MMP9—endothelium—psoriasis	0.00248	0.0441	CbGeAlD
Glucosamine—NFKB2—tendon—psoriasis	0.00185	0.0329	CbGeAlD
Glucosamine—IFNG—skin of body—psoriasis	0.00165	0.0293	CbGeAlD
Glucosamine—IFNG—tendon—psoriasis	0.00125	0.0223	CbGeAlD
Glucosamine—MMP9—skin of body—psoriasis	0.00106	0.0188	CbGeAlD
Glucosamine—MMP9—tendon—psoriasis	0.000805	0.0143	CbGeAlD
Glucosamine—NFKB2—Dexamethasone—Clobetasol propionate—psoriasis	0.000295	0.0968	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Clobetasol propionate—psoriasis	0.000295	0.0968	CbGdCrCtD
Glucosamine—CYP2E1—tendon—psoriasis	0.000265	0.00472	CbGeAlD
Glucosamine—NFKB2—Dexamethasone—Fluocinonide—psoriasis	0.000236	0.0776	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Beclomethasone—psoriasis	0.000236	0.0776	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Fluocinonide—psoriasis	0.000236	0.0776	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Beclomethasone—psoriasis	0.000236	0.0776	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Fluocinolone Acetonide—psoriasis	0.000229	0.0754	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Fluocinolone Acetonide—psoriasis	0.000229	0.0754	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Hydrocortisone—psoriasis	0.000116	0.0381	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Hydrocortisone—psoriasis	0.000116	0.0381	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Betamethasone—psoriasis	0.000108	0.0353	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Dexamethasone—psoriasis	0.000108	0.0353	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Triamcinolone—psoriasis	0.000105	0.0345	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Triamcinolone—psoriasis	0.000105	0.0345	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Prednisone—psoriasis	9.97e-05	0.0328	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Prednisone—psoriasis	9.97e-05	0.0328	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Prednisolone—psoriasis	9.74e-05	0.032	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Prednisolone—psoriasis	9.74e-05	0.032	CbGdCrCtD
Glucosamine—IFNG—Folate Metabolism—IL6—psoriasis	6.53e-05	0.000594	CbGpPWpGaD
Glucosamine—NFKB2—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—psoriasis	6.52e-05	0.000593	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—NFKB1—psoriasis	6.45e-05	0.000586	CbGpPWpGaD
Glucosamine—TNF—TNF receptor signaling pathway —NFKB1—psoriasis	6.44e-05	0.000586	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	6.44e-05	0.000586	CbGpPWpGaD
Glucosamine—IFNG—Selenium Micronutrient Network—TNF—psoriasis	6.43e-05	0.000584	CbGpPWpGaD
Glucosamine—NFKB2—MyD88 dependent cascade initiated on endosome—IL6—psoriasis	6.4e-05	0.000582	CbGpPWpGaD
Glucosamine—NFKB2—Selenium Micronutrient Network—IL6—psoriasis	6.4e-05	0.000582	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—SOCS1—psoriasis	6.39e-05	0.000581	CbGpPWpGaD
Glucosamine—TNF—IL27-mediated signaling events—IL6—psoriasis	6.38e-05	0.00058	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—ICAM1—psoriasis	6.38e-05	0.00058	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—HLA-B—psoriasis	6.36e-05	0.000579	CbGpPWpGaD
Glucosamine—IFNG—Interferon Signaling—TYK2—psoriasis	6.29e-05	0.000572	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—psoriasis	6.26e-05	0.000569	CbGpPWpGaD
Glucosamine—TNF—Transcriptional regulation of white adipocyte differentiation—PPARG—psoriasis	6.25e-05	0.000568	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—NFKBIA—psoriasis	6.23e-05	0.000567	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—IL6—psoriasis	6.23e-05	0.000566	CbGpPWpGaD
Glucosamine—TNF—Ceramide signaling pathway—NFKB1—psoriasis	6.23e-05	0.000566	CbGpPWpGaD
Glucosamine—TNF—Cytokines and Inflammatory Response—IL6—psoriasis	6.19e-05	0.000563	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—HLA-E—psoriasis	6.18e-05	0.000562	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—IL6—psoriasis	6.18e-05	0.000562	CbGpPWpGaD
Glucosamine—NFKB2—Toll Like Receptor 9 (TLR9) Cascade—IL6—psoriasis	6.18e-05	0.000562	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ERAP1—psoriasis	6.12e-05	0.000556	CbGpPWpGaD
Glucosamine—NFKB2—MyD88:Mal cascade initiated on plasma membrane—IL6—psoriasis	6.07e-05	0.000552	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—SOCS1—psoriasis	6.06e-05	0.000551	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—ICAM1—psoriasis	6.05e-05	0.000551	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL4—psoriasis	6.03e-05	0.000548	CbGpPWpGaD
Glucosamine—TNF—Angiopoietin receptor Tie2-mediated signaling—NFKB1—psoriasis	6.03e-05	0.000548	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—TP53—psoriasis	6e-05	0.000545	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IFNG—psoriasis	5.95e-05	0.000541	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—NFKB1—psoriasis	5.93e-05	0.000539	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—HLA-A—psoriasis	5.9e-05	0.000536	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—TP53—psoriasis	5.89e-05	0.000536	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—JUN—psoriasis	5.89e-05	0.000535	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—VEGFA—psoriasis	5.85e-05	0.000532	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	5.85e-05	0.000532	CbGpPWpGaD
Glucosamine—MMP9—CXCR4-mediated signaling events—STAT3—psoriasis	5.84e-05	0.000531	CbGpPWpGaD
Glucosamine—NFKB2—MyD88-independent cascade—IL6—psoriasis	5.83e-05	0.00053	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IFNG—psoriasis	5.8e-05	0.000527	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—IFNG—psoriasis	5.8e-05	0.000527	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—NFKBIA—psoriasis	5.8e-05	0.000527	CbGpPWpGaD
Glucosamine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—NFKB1—psoriasis	5.75e-05	0.000523	CbGpPWpGaD
Glucosamine—NFKB2—Toll-like Receptor Signaling Pathway—IL6—psoriasis	5.69e-05	0.000517	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—NFKB1—psoriasis	5.67e-05	0.000515	CbGpPWpGaD
Glucosamine—TNF—Cardiac Hypertrophic Response—NFKB1—psoriasis	5.58e-05	0.000508	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—CARM1—psoriasis	5.54e-05	0.000504	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—CXCL8—psoriasis	5.53e-05	0.000503	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—TYK2—psoriasis	5.51e-05	0.000501	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—TNF—psoriasis	5.5e-05	0.0005	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—IL6—psoriasis	5.49e-05	0.000499	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—IL6—psoriasis	5.43e-05	0.000494	CbGpPWpGaD
Glucosamine—TNF—amb2 Integrin signaling—IL6—psoriasis	5.41e-05	0.000491	CbGpPWpGaD
Glucosamine—MMP9—EPH-Ephrin signaling—VEGFA—psoriasis	5.39e-05	0.00049	CbGpPWpGaD
Glucosamine—IFNG—Immune System—DDX58—psoriasis	5.39e-05	0.00049	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—HLA-DRB1—psoriasis	5.39e-05	0.00049	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—NFKBIA—psoriasis	5.34e-05	0.000485	CbGpPWpGaD
Glucosamine—NFKB2—Activated TLR4 signalling—IL6—psoriasis	5.24e-05	0.000476	CbGpPWpGaD
Glucosamine—IFNG—Selenium Micronutrient Network—IL6—psoriasis	5.19e-05	0.000472	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—TYK2—psoriasis	5.18e-05	0.000471	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—ICAM1—psoriasis	5.17e-05	0.00047	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—SOCS1—psoriasis	5.16e-05	0.000469	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—TP53—psoriasis	5.16e-05	0.000469	CbGpPWpGaD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—psoriasis	5.15e-05	0.000468	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—LEP—psoriasis	5.1e-05	0.000464	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—STAT3—psoriasis	5.09e-05	0.000463	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—TNF—psoriasis	5.08e-05	0.000462	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ITGAL—psoriasis	5.04e-05	0.000458	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—IFNG—psoriasis	5.02e-05	0.000457	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—TNF—psoriasis	5.02e-05	0.000456	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—JUN—psoriasis	5.01e-05	0.000456	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL10—psoriasis	4.96e-05	0.000451	CbGpPWpGaD
Glucosamine—NFKB2—Toll Like Receptor 4 (TLR4) Cascade—IL6—psoriasis	4.93e-05	0.000448	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—TP53—psoriasis	4.92e-05	0.000447	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IFNG—psoriasis	4.85e-05	0.000441	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—NFKB1—psoriasis	4.83e-05	0.000439	CbGpPWpGaD
Glucosamine—TNF—IL23-mediated signaling events—IL6—psoriasis	4.81e-05	0.000438	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—ICAM1—psoriasis	4.79e-05	0.000435	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—NOS2—psoriasis	4.75e-05	0.000432	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—IL6—psoriasis	4.72e-05	0.000429	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—LEP—psoriasis	4.72e-05	0.000429	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—REL—psoriasis	4.71e-05	0.000429	CbGpPWpGaD
Glucosamine—MMP9—Validated targets of C-MYC transcriptional activation—TP53—psoriasis	4.68e-05	0.000426	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—CXCL8—psoriasis	4.67e-05	0.000425	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IFNG—psoriasis	4.61e-05	0.000419	CbGpPWpGaD
Glucosamine—TNF—Signaling events mediated by HDAC Class I—NFKB1—psoriasis	4.6e-05	0.000419	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IFIH1—psoriasis	4.58e-05	0.000416	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—IL6—psoriasis	4.5e-05	0.000409	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—TP53—psoriasis	4.48e-05	0.000407	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—IL6—psoriasis	4.44e-05	0.000404	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—HLA-B—psoriasis	4.4e-05	0.0004	CbGpPWpGaD
Glucosamine—NFKB2—Toll-Like Receptors Cascades—IL6—psoriasis	4.39e-05	0.000399	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—IL6—psoriasis	4.35e-05	0.000395	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HLA-C—psoriasis	4.34e-05	0.000394	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—TNFAIP3—psoriasis	4.28e-05	0.00039	CbGpPWpGaD
Glucosamine—TNF—Transcriptional regulation of white adipocyte differentiation—NFKB1—psoriasis	4.27e-05	0.000388	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—TYK2—psoriasis	4.2e-05	0.000382	CbGpPWpGaD
Glucosamine—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	4.19e-05	0.000381	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—HCAR2—psoriasis	4.17e-05	0.000379	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—NFKBIA—psoriasis	4.17e-05	0.000379	CbGpPWpGaD
Glucosamine—TNF—Signaling events mediated by HDAC Class I—STAT3—psoriasis	4.14e-05	0.000376	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—JUN—psoriasis	4.13e-05	0.000376	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—PPARG—psoriasis	4.11e-05	0.000374	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—ICAM1—psoriasis	4.11e-05	0.000373	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—IL6—psoriasis	4.1e-05	0.000373	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ITGAL—psoriasis	4.08e-05	0.000371	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—IL6—psoriasis	4.05e-05	0.000368	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—NFKB1—psoriasis	4.04e-05	0.000367	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—psoriasis	3.98e-05	0.000362	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—NFKB1—psoriasis	3.98e-05	0.000362	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CRP—psoriasis	3.89e-05	0.000354	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—STAT3—psoriasis	3.86e-05	0.000351	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TNF—psoriasis	3.85e-05	0.00035	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.85e-05	0.00035	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—JUN—psoriasis	3.84e-05	0.000349	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—NFKB1—psoriasis	3.83e-05	0.000349	CbGpPWpGaD
Glucosamine—IFNG—Immune System—REL—psoriasis	3.82e-05	0.000347	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—CXCL8—psoriasis	3.81e-05	0.000346	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—VEGFA—psoriasis	3.79e-05	0.000345	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—IL6—psoriasis	3.72e-05	0.000339	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IFIH1—psoriasis	3.71e-05	0.000337	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—NFKB1—psoriasis	3.7e-05	0.000336	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IFNG—psoriasis	3.64e-05	0.000331	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—STAT3—psoriasis	3.63e-05	0.00033	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TAGAP—psoriasis	3.62e-05	0.000329	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HLA-E—psoriasis	3.6e-05	0.000327	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—STAT3—psoriasis	3.58e-05	0.000325	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—NFKBIA—psoriasis	3.55e-05	0.000323	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—JUN—psoriasis	3.54e-05	0.000322	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-C—psoriasis	3.51e-05	0.00032	CbGpPWpGaD
Glucosamine—IFNG—Immune System—TNFAIP3—psoriasis	3.47e-05	0.000316	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—NFKB1—psoriasis	3.41e-05	0.00031	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TP53—psoriasis	3.4e-05	0.000309	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—CARM1—psoriasis	3.39e-05	0.000309	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CXCL8—psoriasis	3.39e-05	0.000308	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—TP53—psoriasis	3.31e-05	0.000301	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—NFKB1—psoriasis	3.27e-05	0.000298	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	3.23e-05	0.000294	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IL6—psoriasis	3.11e-05	0.000283	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IL6—psoriasis	3.03e-05	0.000275	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—SOCS1—psoriasis	3.01e-05	0.000273	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—psoriasis	2.97e-05	0.00027	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—STAT3—psoriasis	2.94e-05	0.000267	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-E—psoriasis	2.92e-05	0.000265	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—TYK2—psoriasis	2.91e-05	0.000264	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—TP53—psoriasis	2.87e-05	0.000261	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—TYK2—psoriasis	2.83e-05	0.000258	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—JUN—psoriasis	2.76e-05	0.000251	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—psoriasis	2.73e-05	0.000248	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—CXCL8—psoriasis	2.71e-05	0.000246	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—IL6—psoriasis	2.7e-05	0.000245	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD8A—psoriasis	2.67e-05	0.000242	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—NFKB1—psoriasis	2.66e-05	0.000242	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—LEP—psoriasis	2.65e-05	0.000241	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CD4—psoriasis	2.63e-05	0.000239	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HLA-B—psoriasis	2.56e-05	0.000233	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL6—psoriasis	2.54e-05	0.000231	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—STAT3—psoriasis	2.52e-05	0.000229	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—JUN—psoriasis	2.52e-05	0.000229	CbGpPWpGaD
Glucosamine—IFNG—Immune System—SOCS1—psoriasis	2.44e-05	0.000221	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—NFKB1—psoriasis	2.42e-05	0.00022	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IL6—psoriasis	2.41e-05	0.000219	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HLA-A—psoriasis	2.38e-05	0.000216	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—JUN—psoriasis	2.37e-05	0.000216	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—JUN—psoriasis	2.35e-05	0.000214	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—IL6—psoriasis	2.32e-05	0.000211	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—PPARG—psoriasis	2.31e-05	0.00021	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—NFKB1—psoriasis	2.29e-05	0.000208	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CRP—psoriasis	2.27e-05	0.000206	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—NFKB1—psoriasis	2.27e-05	0.000206	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—VEGFA—psoriasis	2.2e-05	0.0002	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HLA-DRB1—psoriasis	2.17e-05	0.000197	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL20—psoriasis	2.17e-05	0.000197	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD8A—psoriasis	2.16e-05	0.000196	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.14e-05	0.000195	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—IL6—psoriasis	2.14e-05	0.000194	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ICAM1—psoriasis	2.08e-05	0.000189	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TP53—psoriasis	2.08e-05	0.000189	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-B—psoriasis	2.08e-05	0.000189	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—NFKBIA—psoriasis	2.07e-05	0.000188	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.06e-05	0.000188	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL6—psoriasis	2.05e-05	0.000187	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TYK2—psoriasis	2.02e-05	0.000184	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—VEGFA—psoriasis	2e-05	0.000182	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-A—psoriasis	1.93e-05	0.000175	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL6—psoriasis	1.9e-05	0.000173	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—NDUFA5—psoriasis	1.89e-05	0.000172	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.87e-05	0.00017	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CRP—psoriasis	1.84e-05	0.000167	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—IL6—psoriasis	1.76e-05	0.00016	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-DRB1—psoriasis	1.76e-05	0.00016	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—TYK2—psoriasis	1.69e-05	0.000154	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ICAM1—psoriasis	1.69e-05	0.000154	CbGpPWpGaD
Glucosamine—IFNG—Immune System—NFKBIA—psoriasis	1.68e-05	0.000152	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—psoriasis	1.67e-05	0.000152	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IL6—psoriasis	1.67e-05	0.000152	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—LEP—psoriasis	1.62e-05	0.000147	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CYP2S1—psoriasis	1.61e-05	0.000146	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IFNG—psoriasis	1.59e-05	0.000144	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—NFKB1—psoriasis	1.57e-05	0.000143	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TP53—psoriasis	1.57e-05	0.000142	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD4—psoriasis	1.53e-05	0.000139	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL6—psoriasis	1.52e-05	0.000138	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—NDUFA5—psoriasis	1.46e-05	0.000133	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—VEGFA—psoriasis	1.43e-05	0.00013	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—IL6—psoriasis	1.42e-05	0.000129	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—STAT3—psoriasis	1.42e-05	0.000129	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.41e-05	0.000129	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—PPARG—psoriasis	1.41e-05	0.000128	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—IL6—psoriasis	1.39e-05	0.000126	CbGpPWpGaD
Glucosamine—IFNG—Immune System—TYK2—psoriasis	1.37e-05	0.000125	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—JUN—psoriasis	1.37e-05	0.000125	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.36e-05	0.000124	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—NFKB1—psoriasis	1.32e-05	0.00012	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CYP2S1—psoriasis	1.24e-05	0.000113	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD4—psoriasis	1.24e-05	0.000113	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—TYK2—psoriasis	1.24e-05	0.000113	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TNF—psoriasis	1.23e-05	0.000111	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SOCS1—psoriasis	1.19e-05	0.000109	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—STAT3—psoriasis	1.19e-05	0.000108	CbGpPWpGaD
Glucosamine—IFNG—Immune System—JUN—psoriasis	1.11e-05	0.000101	CbGpPWpGaD
Glucosamine—IFNG—Immune System—NFKB1—psoriasis	1.07e-05	9.72e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—IL6—psoriasis	9.89e-06	8.99e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—NFKB1—psoriasis	9.64e-06	8.77e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—STAT3—psoriasis	9.61e-06	8.73e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—LEP—psoriasis	8.81e-06	8.01e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—APOE—psoriasis	8.81e-06	8.01e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—VEGFA—psoriasis	8.75e-06	7.96e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—STAT3—psoriasis	8.67e-06	7.88e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL6—psoriasis	8.28e-06	7.53e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NFKBIA—psoriasis	8.21e-06	7.46e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CARM1—psoriasis	7.86e-06	7.14e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TYK2—psoriasis	6.72e-06	6.11e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL6—psoriasis	6.71e-06	6.1e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.5e-06	5.91e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CARM1—psoriasis	6.06e-06	5.51e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—IL6—psoriasis	6.05e-06	5.5e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCL8—psoriasis	5.85e-06	5.32e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.67e-06	5.15e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—JUN—psoriasis	5.44e-06	4.95e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NFKB1—psoriasis	5.24e-06	4.76e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CAT—psoriasis	4.83e-06	4.39e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—VEGFA—psoriasis	4.75e-06	4.32e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—STAT3—psoriasis	4.71e-06	4.28e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—APOE—psoriasis	3.75e-06	3.41e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CAT—psoriasis	3.73e-06	3.39e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TP53—psoriasis	3.59e-06	3.27e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL6—psoriasis	3.29e-06	2.99e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PPARG—psoriasis	3.27e-06	2.97e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—APOE—psoriasis	2.9e-06	2.63e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PPARG—psoriasis	2.52e-06	2.29e-05	CbGpPWpGaD
